Darzalex
Darzalex Products are primarily used for
Multiple myeloma
About Darzalex Products
Darzalex Products side effects
Common
Side Effects of Darzalex are Gastrointestinal toxicity, Respiratory tract infection, Increased liver enzymes, Headache, Decreased appetite, Joint inflammation, Chest pain, Decreased potassium level in blood, Weakness, Infection, Muscle spasm, Insomnia (difficulty in sleeping), Peripheral edema, Infusion reaction, Altered blood cell count, Fatigue, Back pain.
How Darzalex Products work
Daratumumab is a monoclonal antibodies, which are designed to recognise and attach to specific proteins on the surface of cancer cells. It shows its action by binding to specific cancer cells in the body and helps your immune system kills cancer.
Patient Concerns about Darzalex Products
Frequently asked questions about Darzalex Products
Frequently asked questions about Daratumumab
Q. What is Darzalex Injection used for?
Darzalex Injection is prescribed for adults with multiple myeloma (a type of cancer of plasma cells) and may be given alone or with other medicines, depending on the treatment plan and prior therapies.
Q. What are the most important infusion-related warnings of Darzalex Injection?
Infusion reactions due to Darzalex Injection can be serious or life-threatening, especially during the first doses, causing trouble breathing, wheezing, chest discomfort, fast heartbeat, blood pressure changes, swelling, severe headache, or vision changes. Infusions are slowed, paused, or stopped, and emergency care is given if reactions occur.
Q. Can Darzalex Injection affect blood transfusions or blood tests?
Yes, Darzalex Injection can cause a positive indirect Coombs test and interfere with matching blood for transfusions for up to six months after the last dose, so a blood type and screen is done before starting this medicine, and blood banks must be informed about current or recent treatment.
Q. Does Darzalex Injection lower blood counts?
Darzalex Injection can reduce white blood cells (raising infection risk) and platelets (raising bleeding risk), so regular blood tests are done, and dosing may be delayed until counts recover when needed.
Q. Can hepatitis B reactivate with Darzalex Injection?
Yes, hepatitis B can reactivate with Darzalex Injection, rarely causing severe illness. Doctors check hepatitis B status before, during, and after treatment and monitor for symptoms such as worsening tiredness or yellowing of eyes/skin.
Q. Does Darzalex Injection change how doctors measure myeloma response?
Yes, Darzalex Injection can appear on serum protein tests (SPEP/IFE) and look like the myeloma protein, potentially masking a complete response. Specialized assays may be used to distinguish the medicine from the disease protein when needed.
Q. Are there special cautions for breathing or eye symptoms during receiving Darzalex Injection?
People with chronic lung disease may need extra inhaled medicines in addition to receiving Darzalex Injection. Additionally, any new eye pain, blurred vision, or acute vision changes during receiving Darzalex Injection should trigger an immediate pause and urgent eye evaluation before restarting.
Q. What should be done before starting Darzalex Injection treatment to improve safety?
Before starting Darzalex Injection, your doctor will check your blood type and hepatitis B status, plan medicines to prevent infusion reactions, and arrange regular blood count monitoring. You should also inform your doctor about any past infections, lung problems, and all medicines or supplements you’re taking.
Products for Darzalex
Darzalex Injection
vial of 5 ml Injection
MRP
₹18900
Darzalex 400mg Injection
vial of 1 Injection
MRP
₹75500